Cost-effectiveness of Platelet Function-Guided Strategy with Clopidogrel or Ticagrelor
Some patients treated with dual antiplatelet therapy (DAPT) following acute coronary syndrome (ACS) can still exhibit heightened residual platelet reactivity (HRPR), which is potentially linked to adverse vascular outcomes. Better tailored DAPT strategies are needed to address this medical need. Aim...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Radcliffe Medical Media
2019
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/a91ec16800854a1d82afd0cd6c911f1e |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|